CME · CME Group Inc.
CME Group Inc. (CME) — leading operator of global listed derivatives and clearing services. Near-term research focus: how expanding prediction/event markets and related clearing economics could create optionality for incumbents.
Recent proof-backed thesis calls
Recent thematic coverage centers on prediction markets and event-contract growth. ARK Invest episodes referenced a partnership with Kalshi and discussed how such platforms could produce new signals for markets. Internal coverage also noted broader macro commentary (e.g., Jason Trennert) in the context of market structure and policy.
Cathie Wood (ARK Invest) discusses macro signals (inflation/jobs/war) and highlights an unexpected divergence between PPI and CPI. The main concrete item is ARK’s announced partnership with Kalshi (a regulated prediction-market platform), framed as a potential catalyst for a broader “financial innovation wave” and new data/signals for markets.
Podcast episode featuring Kalshi’s Head of Research discussing prediction markets and how they could be used for forecasting and risk management. The excerpt provided contains no concrete corporate news, financial results, partnership announcement, regulatory decision, or product launch tied to a publicly traded company—mostly high-level discussion about the prediction-market category and Kalshi’s mission/background.
Latest market-close explanation
On 2026-04-13 CME closed at $300.59, up 1.79% from $295.30; intraday range $295.83–$300.74 and volume was down 46.9% versus the prior session. Latest coverage referenced ARK Invest and internal podcasts discussing prediction markets.
**CME** (CME Group Inc.) moved **+1.79%** on 2026-04-13, closing at **$300.59** after a previous close of **$295.30**. Intraday range was **$295.83** to **$300.74**. Volume changed **-46.9%** versus the prior session. Recent internal coverage also touched CME: **Jason Trennert on Populism, Policy & a Distorted Market System | The Real Eisman Playbook Episode 44**.
Current stance
Current stance: buy. Research views CME as a beneficiary via category optionality—incumbent derivatives and clearing operators could gain if prediction markets and event contracts expand under clearer regulation.
- beneficiary via Category optionality: incumbents benefit if prediction markets/event contracts expand under clearer regulation. from https://www.youtube.com/@ARKInvest2015 (confidence 0.34)
- beneficiary via Prediction markets as an emerging mainstream financial product layer from https://www.youtube.com/@ARKInvest2015 (confidence 0.30)
Top authors on this asset
Active and historical ticker theses
Active plays emphasize the potential for listing and clearing event-risk contracts to drive second-order benefits for the large-cap derivatives ecosystem. Relevant pieces: "Kalshi Beats Consensus | The Brainstorm EP 125" and "Inflation, Jobs, War: Kalshi’s Signals | ITK With Cathie Wood."
Category optionality: incumbents benefit if prediction markets/event contracts expand under clearer regulation.
Prediction markets as an emerging mainstream financial product layer
Unlock full asset monitoring
Monitor regulatory developments around prediction markets and any concrete product or partnership announcements that would affect listing, clearing, or revenues for CME.